SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Nektar Therapeutics
(NASDAQ : NKTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading NKTR News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.62%78.761.2%$808.66m
SRPTSarepta Therapeutics, Inc.
6.01%62.6530.9%$457.85m
AMGNAmgen Inc.
-1.12%169.711.1%$455.78m
BIIBBiogen Inc.
-1.29%310.461.0%$427.66m
MDVNMedivation, Inc.
0.05%81.481.9%$415.69m
CELGCelgene Corporation
-1.67%105.610.8%$376.73m
REGNRegeneron Pharmaceuticals, Inc.
-0.20%420.603.2%$312.21m
CPHDCepheid
0.04%52.654.7%$211.12m
ALXNAlexion Pharmaceuticals, Inc.
-1.48%124.122.3%$171.46m
CLVSClovis Oncology, Inc.
-1.74%36.7925.5%$161.49m
ILMNIllumina, Inc.
0.21%180.723.4%$139.07m
VRTXVertex Pharmaceuticals Incorporated
-0.39%88.772.2%$123.39m
BMRNBioMarin Pharmaceutical Inc.
-0.87%96.213.8%$112.48m
INCYIncyte Corporation
4.23%92.842.7%$110.97m
TSROTESARO, Inc.
-3.45%104.3115.9%$107.95m

Company Profile

Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Its products includes of drug candidates of therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. It provides small molecule drugs, peptides and other potential biologic drug candidates. It's drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. The company was founded in 1990 and is headquartered in San Francisco, CA.